Insiders · LENZ

LENZ insider transactions

LENZ Therapeutics Inc. (LENZ) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for LENZ

• 70d
  SEC Form 4 filed by George Jeffrey P.

  4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
• 70d
  SEC Form 4 filed by Schimmelpennink Evert B.

  4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
• 70d
  SEC Form 4 filed by Chevallard Daniel R.

  4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
• 153d
  SEC Form 4 filed by Chief Commercial Officer Olsson Shawn

  4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
• 153d
  SEC Form 4 filed by Chief Medical Officer Odrich Marc

  4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
• 153d
  SEC Form 4 filed by Chief Financial Officer Chevallard Daniel R.

  4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
• 153d
  SEC Form 4 filed by President, CEO and Secretary Schimmelpennink Evert B.

  4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
• 201d
  Chief Commercial Officer Olsson Shawn exercised 10,000 shares at a strike of $2.08 and sold $261,022 worth of shares (10,000 units at $26.10) (SEC Form 4)

  4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
• 210d
  Director Mccollum James W bought $239,278 worth of shares (10,500 units at $22.79) (SEC Form 4)

  4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
• 213d
  Chief Financial Officer Chevallard Daniel R. bought $50,017 worth of shares (2,198 units at $22.76), increasing direct ownership by 69% to 5,386 units (SEC Form 4)

  4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
• 249d
  Large owner Versant Venture Capital Vi, L.P. sold $10,352,017 worth of shares (224,974 units at $46.01) (SEC Form 4)

  4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
• 259d
  Large owner Versant Venture Capital Vi, L.P. sold $5,714,356 worth of shares (135,304 units at $42.23) (SEC Form 4)

  4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
• 286d
  Large owner Versant Venture Capital Vi, L.P. sold $7,423,920 worth of shares (188,094 units at $39.47) (SEC Form 4)

  4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
• 293d
  Large owner Versant Venture Capital Vi, L.P. sold $10,255,244 worth of shares (260,713 units at $39.34) (SEC Form 4)

  4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
• 329d
  Large owner Versant Venture Capital Vi, L.P. sold $6,506,784 worth of shares (191,376 units at $34.00) (SEC Form 4)

  4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
• 342d
  Large owner Versant Venture Capital Vi, L.P. sold $6,093,000 worth of shares (200,000 units at $30.46) (SEC Form 4)

  4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
• 353d
  Large owner Versant Venture Capital Vi, L.P. sold $10,107,818 worth of shares (334,801 units at $30.19) (SEC Form 4)

  4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
• 361d
  Large owner Versant Venture Capital Vi, L.P. sold $10,150,000 worth of shares (350,000 units at $29.00) (SEC Form 4)

  4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
• 362d
  SEC Form 4 filed by Director Ra Capital Management, L.P.

  4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
• 362d
  SEC Form 4 filed by Director George Jeffrey P.

  4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
• 362d
  SEC Form 4 filed by Director Drapkin Kimberlee C

  4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
• 362d
  SEC Form 4 filed by Director Guerard Frederic

  4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
• 362d
  SEC Form 4 filed by Director Thunen Shelley B

  4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
• 362d
  SEC Form 4 filed by Director Mccollum James W

  4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
• 362d
  SEC Form 4 filed by Director Scheiner Zachary

  4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
• 425d
  Chief Commercial Officer Olsson Shawn exercised 1,400 shares at a strike of $2.08, increasing direct ownership by 42% to 4,733 units (SEC Form 4)

  4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
• 458d
  President, CEO and Secretary Schimmelpennink Evert B. exercised 4,200 shares at a strike of $1.04, increasing direct ownership by 9% to 49,200 units (SEC Form 4)

  4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
• 511d
  SEC Form 4 filed by Chief Commercial Officer Olsson Shawn

  4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
• 511d
  SEC Form 4 filed by Chief Medical Officer Odrich Marc

  4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
• 511d
  SEC Form 4 filed by Chief Financial Officer Chevallard Daniel R.

  4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
• 511d
  SEC Form 4 filed by President, CEO and Secretary Schimmelpennink Evert B.

  4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
• 538d
  Chief Commercial Officer Olsson Shawn exercised 3,333 shares at a strike of $2.08 (SEC Form 4)

  4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
• 685d
  President, CEO and Secretary Schimmelpennink Evert B. exercised 45,000 shares at a strike of $1.04 (SEC Form 4)

  4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)
• 754d
  Chevallard Daniel R. bought $49,988 worth of shares (3,188 units at $15.68) (SEC Form 4)

  4 - LENZ Therapeutics, Inc. (0001815776) (Issuer)